Skip to main content
University of California San Francisco
UCSF School of Medicine | Department of Pediatrics UCSF Medical Center

B-cell differentiation and IL-21 response in IL2RG/JAK3 SCID patients after hematopoietic stem cell transplantation.

  • Read more about B-cell differentiation and IL-21 response in IL2RG/JAK3 SCID patients after hematopoietic stem cell transplantation.

Preclinical efficacy of daratumumab in T-cell acute lymphoblastic leukemia.

  • Read more about Preclinical efficacy of daratumumab in T-cell acute lymphoblastic leukemia.

Reduced-Intensity Conditioning Is Successful in Matched Sibling Bone Marrow Transplantation As a Cure for Sickle Cell Disease

  • Read more about Reduced-Intensity Conditioning Is Successful in Matched Sibling Bone Marrow Transplantation As a Cure for Sickle Cell Disease

Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study.

  • Read more about Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study.

Robust patient-derived xenografts of MDS/MPN overlap syndromes capture the unique characteristics of CMML and JMML.

  • Read more about Robust patient-derived xenografts of MDS/MPN overlap syndromes capture the unique characteristics of CMML and JMML.

Reticular dysgenesis: international survey on clinical presentation, transplantation, and outcome.

  • Read more about Reticular dysgenesis: international survey on clinical presentation, transplantation, and outcome.

Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation.

  • Read more about Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation.

Daratumumab Is Effective in the Treatment of Refractory Post-Transplant Autoimmune Hemolytic Anemia: A Pediatric Case Report.

  • Read more about Daratumumab Is Effective in the Treatment of Refractory Post-Transplant Autoimmune Hemolytic Anemia: A Pediatric Case Report.

Azacitidine Administration Following Hematopoietic Stem Cell Transplantation Is Safe and Feasible in Children with Acute Leukemia.

  • Read more about Azacitidine Administration Following Hematopoietic Stem Cell Transplantation Is Safe and Feasible in Children with Acute Leukemia.

Efficacy and safety of long-term RN-1 treatment to increase HbF in baboons.

  • Read more about Efficacy and safety of long-term RN-1 treatment to increase HbF in baboons.

Pagination

  • Previous page ‹‹
  • Page 11
  • Next page ››
Subscribe to Blood

Pediatrics Home

MAKE A GIFT

© 2022 The Regents of the University of California. The University of California San Francisco  |  UCSF Department of Pediatrics                                                                                              Accessibility  Privacy Policy  Terms of Use  A-Z Website List